Cardiovascular Care in Pediatric Cancer Survivors: Updates on Risk, Prevention, and Therapies
Current Treatment Options in Oncology · 2026-12 · 27 (1)
DOI: 10.1007/s11864-025-01367-9 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Treatment Options in Oncology, online erschienen am 24.12.2025. Verfasst von Heang M Lim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Cardiology, University of Michigan, CS Mott Children's Hospital, 1540 East Hospital Drive, Ann Arbor, MI, 48109-4204, USA. HeangL@med.umich…. Hauptthemen laut MEDLINE: Cancer Survivors, Cardiovascular Diseases, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Opinion Statement Improved survival in pediatric oncology has highlighted the growing burden of cancer treatment-related cardiotoxicity among survivors of childhood cancers. While the cardiotoxicity of anthracyclines and chest radiation are well documented as major contributors of late morbidity and mortality, the rapid adoption of immunotherapies and targeted agents in pediatrics raises new concerns regarding the unknown long-term cardiovascular risk. Recent advances include risk-adapted surveillance protocols and pediatric-based imaging guidelines are important steps towards optimizing early detection and intervention. However, significant gaps persist, particularly in the development of effective treatment options for cardiotoxicity, consistent cardiovascular event reporting, seamless transitions to adult care, and the meaningful integration of machine learning and precision medicine into real-world practice. In light of these ongoing challenges, we believe that while national and international guidelines are an essential framework, optimal cardiology care for pediatric cancer survivors must be grounded in individualized assessment and supported by multidisciplinary collaboration. Ongoing research and innovation are imperative to closing these gaps and advancing the long-term cardiovascular outcomes of this vulnerable population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric Cardiology, University of Michigan, CS Mott Children's Hospital, 1540 East Hospital Drive, Ann Arbor, MI, 48109-4204, USA. HeangL@med.umich.edu.
- Department of Pediatrics, University of Cincinnati College of Medicine, Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
- Pediatric Cardiology, Le Bonheur Children's Hospital, University of Tennessee Health Science Center, Memphis, TN, USA.
- Pediatric Cardiology, Duke University Medical Center, Durham, NC, USA.
- Pediatric Cardiology, Mount Sinai Kravis Children's Hospital, New York, NY, USA.
Zitieren
APA
Lim, H. M., Ryan, T. D., Miller, E., Shea, E., & Bansal, N. (2026). Cardiovascular Care in Pediatric Cancer Survivors: Updates on Risk, Prevention, and Therapies. Current Treatment Options in Oncology, 27(1). https://doi.org/10.1007/s11864-025-01367-9
Vancouver
Lim HM, Ryan TD, Miller E, Shea E, Bansal N. Cardiovascular Care in Pediatric Cancer Survivors: Updates on Risk, Prevention, and Therapies. Current Treatment Options in Oncology. 2026;27(1). doi:10.1007/s11864-025-01367-9
BibTeX
@article{Lim2026,
author = {Lim, Heang M and Ryan, Thomas D and Miller, Elyse and Shea, Erin and Bansal, Neha},
title = {Cardiovascular Care in Pediatric Cancer Survivors: Updates on Risk, Prevention, and Therapies},
journal = {Current Treatment Options in Oncology},
year = {2026},
volume = {27},
number = {1},
doi = {10.1007/s11864-025-01367-9}
}
EUVIMED